Previous PostIVIEW Announces Presentation of Positive Topline Results in Phase II Clinical Study of IVIEW-1201 for the Treatment of Bacterial Conjunctivitis at ARVO 2024
Next PostVenatorx and Melinta Provide Update on Status of U.S. New Drug Application for Cefepime-Taniborbactam